20
Participants
Start Date
August 1, 2019
Primary Completion Date
January 1, 2026
Study Completion Date
September 1, 2026
Symdeko
explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs.
RECRUITING
University of Alabama at Birmingham, Birmingham
George Solomon
OTHER